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ABSTRACT
The promiscuous streptococcal plasmid pLSI encodes for the 5.1 kDa RepA protein, involved in
the regulation of the plasmid copy number. Synthesis of RepA was observed both in Bacillus subtilis
minicells and in an Escherichia coli expression system. From this system, the protein has been purified
and it appears to be a dimer of identical subunits. The amino acid sequence of RepA has been
determined. RepA shows the cshelix-tumr-ahelix motif typical of many DNA-binding proteins and
it shares homology with a number of repressors, specially with the TrfB repressor encoded by the
broad-host-range plasmid RK2. DNase I footprinting revealed that the RepA target is located in the
region of the promoter for the repA and repB genes. Trans-complementation analysis showed that
in vivo, RepA behaves as a repressor by regulating the plasmid copy number. We propose that the
regulatory role of RepA is by limitation of the synthesis of the initiator protein RepB.
INTRODUCTION
Promiscuous plasmids are usually restricted to hosts of the same type, Gram-positive or
Gram-negative (1). However, a few examples of plasmids that are able to surpass the so-
called barrier between both types of eubacteria have been described (2,3). Among them,
the best characterized replicon so far is the streptococcal multicopy plasmid pLS 1, which
is capable of autonomous replication in Streptococcus pneumoniae, B. subtilis and E. coli
(3). This 4408-bp plasmid is unusual because it shows features typical to both Gram-positive
and Gram-negative replicons. Plasmid pLS1 replicates by assymmetric rolling circle (4),
as other small staphylococcal plasmids (5). On the other hand, like many Gram-negative
replicons, pLS 1 has three iterons that are included in its ori(+) (6). Regulation of pLS1
replication involves two genes: repB that codes for the site-specific initiator protein RepB
(de la Campa et al., in preparation); and repA, placed upstream of repB, transcribed in
the same mRNA and that specifies for a small protein RepA. RepA binds to and induces
DNA bending in a plasmid region that includes the repAB promoter and the three iterons,
and we have suggested that the protein could act as a repressor involved in the regulation
of the synthesis of RepB (4,6,7).
Regulation of gene expression can be performed through a variety of mechanisms. One
of them, best characterized in bacteriophages, is exerted through the interaction of a
repressor protein with its operator target(s) (8). Several instances of phage- and of E. coli-
encoded repressor proteins are very well characterized (8-12). However, information
on plasmid-encoded repressor proteins is not so well documented (1). In the narrow host-
range plasmid RI, a repressor protein, CopB, is involved in the control of the transcription
from the repA promoter to synthesize the mRNA for the replication initiator protein RepA
(13-16). In the case of the broad host-range plasmid RK2 two proteins, KorB and TrfB,
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have been shown to act independently (and postulated to cooperate) in the regulation of
transcription from the trfA and trJB promoters to limit the rate of synthesis of the replication
initiator protein TrfA (1,17, and references therein). However, no information on repressor
proteins that exert an inhibitor-target regulation is so far available for the small, multicopy
Gram-positive plasmids (18,19).
Here we report the characterization of the pLS 1-encoded RepA protein and its synthesis
in two hosts: B. subtilis minicells (under the repA own transcription/translation signals)
and E. coli (under the control of a phage T7 promoter for the T7 RNA polymerase). The
protein has been hiperproduced, purified and its amino acid sequence determined. RepA
shares homology with a variety of repressors in a domain that shows the cxhelix-turn-ohelix
motif found in many DNA-binding proteins (20). In addition to this, the amino terminal
region of RepA shows a high degree of homology with regions of some regulatory proteins,
specially with the RK2-repressor TrfB (17). By DNase I footprinting, the target of RepA
has been located at the repAB promoter. Cloning of the wild type and of a repA mutant
(cop7) genes into plasmid pC194 allowed us to perform trans-complementation analysis
in S.pneumoniae. We observed a RepA-conditioned reduction in the number of copies
of the pLSlcop7 mutant, indicating that RepA acts as a repressor for the regulation of
pLSI copy number. We propose that RepA-repression is exerted by limitation of the
synthesis of the initiator protein RepB.
MATERIALS AND METHODS
Bacterial strains and plasmids.
The E.coli strains used were C600 (thr-1 thi-1 leu-6 lacYl JhuA21 supE44), BL21 (F-
hsdR gal) and its isogenic strain BL2 IDE3 the two latter kindly provided by F.W.Studier.
The BL21DE3 strain contains a single copy of the gene for phage T7 RNA polymerase
in the chromosome under the control of the inducible lacUV5 promoter (2 1). The minicell-
producing strain was B.subtilis CU403 (divBIV thyA thyB metB). S.pneumoniae 708 (end-I
exo-2 trt-1 hex-4 malM594) was employed for the preparation of pLS1-based plasmids
and for the complementation assays. Plamids used were: pLS1 and pLS5 (3), the deleted
derivative pLS 1I 24 (6), the high copy number mutant pLSlcop7 (4, this work), the
expression vector pET5 (21,22) and the constructions described in this work. Plasmid pET5
(a gift of F.W.Studier) is a pBR322-based transcription vector in which the phage T7 RNA
polymerase 410 promoter has been cloned (21,22).
Transformations, DNA preparations and DNA manipulations.
Procedures for the transformation of the three bacterial species used have been described
(3,4,23). Construction and analysis of recombinant plasmids were performed either in the
C600 or BL21 strains (for the pET5-based plasmids) or in S.pneumoniae (for the
pC194-based reconibinants). To induce the expression of cloned genes under the control
of the phage T7 410 promoter, various plasmids (see Fig. 1) were transferred to the
BL21DE3 strain. Selection for ampicillin in these strains was of 200 Ag/ml to avoid the
overgrowth of plasmid-free cells (21,22). Preparations of pure plasmid DNA and enzymatic
treatments of DNA were done as reported (4). Sequencing of the cop7 mutation was
performed from plasmid pJS3 (3) at S.A.Lacks' laboratory. The mutation was transferred
to plasmid pLS1 by exchange of the fragment PstIB and its presence was confirmed by
DNA sequencing. DNA sequence determinations were performed by the chemical method
of Maxam and Gilbert (24).
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Synthesis of proteins in minicells.
Preparation of B. subtilis minicells was as reported (25). Plasmid-encoded proteins in the
minicells were analyzed by labelling with [35S]methionine, [3H]valine or [3H]lysine
followed by electrophoresis in 5% to 25% SDS -polyacrylamide gradient gels, as described
(3,25). Under these conditions, the products of the pLS 1-encoded tet and repA genes were
visualized, but not the product of the repB gene.
Gene expression under the phage 77 J10 promoter.
Before preparation of extracts, E.coli BL21DE3 cultures carrying plasmids with the O10
promoter were routinely checked to calculate the percentage of cells with a functional system
and of plasmid-free cells (21). Various plasmid constructions and several conditions for
induction of the T7 RNA polymerase with isopropyl-fl-D-thiogalactopyranoside (IPTG)
were tested. After analysis of the proteins synthesized in low-scale cultures, the plasmid
chosen was pLS 19 (Fig. 1) and the conditions to get the highest yield of RepA were:
incubation at 37°C, induction with 0.5 mM IPTG for 7 min followed by addition of 200
Ag/ml rifampicin (freshly prepared at 10 mg/ml in dimethyl sulfoxide) and subsequent
incubation for 3 h. At this time, 2 ml-culture samples were withdrawn, labelled with
[35S]methionine for 10 min and disrupted, as described (3). The proteins were separated
by SDS -polyacrylamide gel electrophoresis (SDS -PAGE) in 10% to 20% gradient gels.
Determination of the size of small polypeptides was done by SDS-urea-PAGE (15%
acrylamide, following the protocol recommended by BRL in Focus 6:3). The labelled
proteins were analyzed by fluorography. Protein concentration was determined by the use
of the BCA protein assay (Pierce, USA).
Determination of the native molecular weight of RepA.
The native molecular weight of RepA was determined by sedimentation in glycerol gradients
and by gel filtration in agarose. The first procedure was performed essentially as described
(26), but the gradients were run at 4°C for 20 h. Gel filtration was done on agarose (Bio
Rad A-0.5m, 200-400 mesh) in a 1.2cmx37cm column, with a sample volume of 300
ml and a flow rate of 6 ml/h, as reported (10).
Amino acid sequence deternination.
Automatic sequencing of the intact protein was done in a pulsed gas -liquid phase sequencer
(27) (Applied Biosystems, mod. 477A) with on-line detection of the PTH amino acids
by HPLC using a gradient system (Applied Biosystems PTH-analyzer, mod. 120A). The
protein was dissolved in 20 kdl 100% TFA and spread into a glass fiber disk (GF) which
was precycled with 2 mg Polybrene.
DNase Ifootprinting.
Plasmid pLS1A 24 has a clockwise 570-bp deletion including coordinates 4240 to 401
of pLS1 (6). pLS1A 24 DNA (8.5 tig) was digested with Hinfl, the fragments were 5'-
end labelled, digested with EcoRI, HindIfl and NcoI and the resulting ten fragments were
separated by non-denaturing 5% PAGE as described (4). The 302 bp NcoI-Hinfl fragment(coordinates 4221 to 685 of pLS1; containing the repAB promoter) was eluted, ethanol-
precipitated and recovered at the specific activity of 107 cpm/mg. Each reaction (50 Al)
contained 5 ng of the labelled fragment, 2 mM MnCl2, 100 mM KCl, 20 mM Tris HCl
(pH 8.0), 1 mM EDTA, 5 mM DTT, 5% ethylene glycol. In the RepA-containing reactions,
two amounts (1 jig and 0.1 jg) of the protein were used. The mixtures were incubated
15 min at 20°C and then, 0.007 units of DNase I (2.7 units/mg, RNase- and protease-
free, Cooper Biomedical, USA) were added. Incubation proceeded for another 5 min and
the reactions were stopped by the addition of 25 Al of a 2 M ammonium acetate, 0.15
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Figure 1. Expression of repA. A: Gene expression of repA under its own transcription/translation signals detected
by SDS-PAGE and fluorography of labelled pLS1-encoded proteins synthesized in B.subtilis minicells. Amounts
applied corresponded to about 8 jig of total cell protein. The position of unlabelled molecular weight standards
(bovine serum albumin, ovoalbumin, chymotrypsinogen and lysozyme) is indicated on the left. B: Expression
under the control of the phage T7 J10 promoter in E.coli detected by SDS-PAGE and fluorography of labelled
proteins synthesized in IPTG-induced cultures of E.coli BL21DE3 harbouring the indicated plasmids. Only the
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M EDTA, 0.8 M Na-acetate solution containing 100 Atg/ml of sonicated calf thymus DNA
and 400 p4g/ml tRNA. DNA was ethanol-precipitated, washed and suspended in 18 1l
of sequencing loading buffer (24). A 6 IlI sample (about 17,000 cpm) was loaded into
0.4 mm-thick 8% polyacrylamide sequencing gels (24) and run together with the sequencing
reactions of the same fragment. Electrophoresis was conducted at 2000 V and was stopped
28 min after the bromophenol blue left the gel.
Trans-complementation analysis.
The repA gene was cloned into the unique HindIH site of a copy number mutant of pC 194
(Ballester et al., in preparation), by digestion of pLSl DNA with AluI and BglI. The cohesive
ends were eroded with nuclease SI and made blunt, the DNA fragments ligated and used
to transform competent S.pneumoniae cells. Selection for chloramphenicol resistance and
screening of appropriate recombinants allowed the isolation and identification of a plasmid,
termed pCGA3. This plasmid contains a pLS 1 insert spanning from coordinates 505 to
804 in which the three iterons and the entire repA gene (with its own promoter) are included.
The copy number of pCGA3 is about 200 per genome equivalent, as measured by
densitometric scanning (28). This plasmid showed full structural and generational stability.
To construct pCGA3cop7, the ApaLI -StyI fragment of the cloned pLS 1-wild type region
was changed for the corresponding cop7 fragment. The complementation tests were carried
out by transformation of competent cells harbouring resident plasmids and by selection
for the donor marker. Although the pneumococcal strain used was rec+ and donor and
resident plasmids shared 300 bp homology, few instances of recombination between them
were observed. Analysis of plasmid content in the transformants was performed by
preparation of crude extracts from exponentially growing cultures at 4 x 108 viable cells/ml
and agarose gel electrophoresis (4). The number of copies by genome equivalent were
determined as above (28).
Densitometric scannings and computer work.
Soft laser densitometric scannings were performed in a LKB Ultroscan 2202 coupled to
an Apple II computer. Search for homologies of RepA with the P.I.R. data bank resource
was done with the use of the DNASTAR computer programs (DNASTAR, Inc., UK).
Prediction of secondary structure of RepA was performed with the aid of the program
PEPLOT (29), included in the UWGCG computer programs. In addition, the program
PLOTCHOUFASMAN (developed by B.Jameson, S.Modrow, M.Moth and H.Wolf of
the Max von Pettenkofer Institute of the University of Munich) was employed for the graphic
output in the prediction of the secondary structure of RepA.
best conditions for expression are shown. For pLS 19, IPITG was added 7 min before rifampicin and the total
incubation time was of 3 h. For pLS20 and pLS2 1, IPTG and rifampicin were added at the same time and the
incubation times were of 3 h (pLS20 and left track of pLS21) or of 1 h (right track of pLS21). For pLS22,
IPTG was added 7 min before (left track) or simultaneously to (right track) the addition of rifampicin and the
total incubation time was of 3 h. Amounts applied were corrected to load approximately 10 ,ig of total cell protein.
The position of the products of genes tet, bla, repB and repA is indicated. The position of the unlabelled molecular
weight standards (phosphorylase b, bovine serum albumin, ovoalbumin, carbonic anhydrase, trypsin inhibitor
and cx-lactalbumin) is indicated on the right. C: (upper) Maps of the pET5-based plasmids constructed in this
work. Black dot and arrow indicates the position of the 10 promoter. The deletion in pLS5 is indicated. Only
the pertinent gene products (filled arrows) and restriction sites are shown (E:EcoRI; A:ApaLI; Pv:PvuI; P:Pstl;
S:Sall; B:Bcll). Derivatives of plasmid pLS21 were constructed as follows: pLS20 by removal of the PvuI-Sall
fragment of the pET5 moiety; pLS22 by deletion of the PstIB fragment of the pLSl moiety and pLS19 by deletion
of the Bcll fragments of pLSl. (lower) Nucleotide sequence of the pLSI region pertinent for this work. The
two possible overlapping promoters, the ApaLI site, the putative ribosomal binding site (S.D.) and the initiation
codon of RepA are indicated.
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Figure 2. Purification of RepA. A: Agarose, DEAE Sephacell and Heparin-agarose fractionations. Appropriate
fractions (horizontal bar) were pooled and applied to the columns, as indicated in the text. B: Proteins revealed
by Coomassie Blue staining after SDS -urea-PAGE. St: molecular weight standards (ovoalbumin, ce-
chymotripsinogen, (-lactoglobulin, lysozyme, cytochrome C, bovine trypsine inhibitor and insulin). C: fluorography
of the same gel. CE: crude extracts, labelled (L) or unlabelled (U).
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RESULTS AND DISCUSSION
Expression of repA
To demonstrate that pLSI codes for RepA and to show the RepA synthesis, differential
labelling of proteins in B.subtilis minicells was performed with three different amino acids.
As shown in Fig. lA, synthesis of RepA was only visualized when tritiated amino acids
were used (instead of the commonly used [35S]methionine) in spite of the low content of
Val residues (4%) of RepA as compared to the Met (9%) or Lys (16%) content. We ascribe
such a difference to the 70-fold intensification obtained by the fluorographic detection of
3H over 35S. The results show that RepA is synthesized in B. subtilis from pLSl, under
its own transcription and translation signals. The repAB mRNA start point has been located
by SI mapping (not shown) and two possible overlapping promoters could be ascribed
(Fig. IC). We favour the promoter situated more upstream because it shows the consensus
spacer of 17 nucleotides (30) instead of the short 15-nucleotides spacer of the downstream
promoter. If this is the case, the repAB promoter would correspond to the one previously
proposed (3).
The pET5 vector/BL21DE3 host cloning system allows the specific and efficient synthesis
(and the labelling) of proteins encoded by plasmid-borne genes under the control of the
T7 410 promoter (21,22). We could only clone in pET5 the pLSI- derivatives with the
332-bp deletion of pLS5 (3), probably because of the reported homology between this
pLSI region and the pBR322 origin (31). To unequivocally identify the pLS1-encoded
gene products, different plasmid constructions were made (Fig. IC). Plasmid pLS21 is
a composite between pET5 and pLS5. Deletion of the bla gene of pLS21 and identification
of the repB gene product were achieved by the construction of pLS20. In addition,
identification of the repA and repB gene products was possible by construction of pLS22,
in which the PstIB fragment of pLSI was removed. IPTG-induced cells carrying pLS20
or pLS21 showed high levels of synthesis of RepA and RepB, whereas no detectable levels
of these proteins were observed for cells harbouring pLS22 (Fig. iB). Reorientation of
the pLS5 moiety (from pLS20) in relation to the 010 promoter abolished the synthesis
of pLS1-coded proteins (results not shown). The product of the tet gene of pLS1 could
not be detected, perhaps because it is a membrane-bound protein (3). Since the cells did
not grow well when the tet gene was present, it seemed that its product was toxic to the
host (not shown). Consequently, pLSl9 (in which the tet gene was deleted) was the best
vector for high expression levels of RepA. Once the conditions of induction with this plasmid
were optimized, we could obtain a high yield of RepA, amounting to about 5% of the
total cell protein.
Purification of RepA
Purification of RepA from induced cultures of E. coli BL21DE3 carrying pLS 19 was
achieved as follows (Fig.2). Step 1: One litre of an exponentially growing culture (3 x 108
cell/ml) was induced under the conditions described in Methods. The cells were collected
by centrifugation, washed with 100 ml of buffer A (500 mM NaCl, 20 mM Tris HCl
(pH 7.5), 1 mM EDTA, 1mM DTT, 5% ethylene glycol) and suspended in 10 ml of the
same buffer. The cell paste was passed twice through a chilled French-pressure cell at
20,000 psi. The lysate was centrifuged at 15,000 x g 20 min and divided into 2.5-ml
aliquots. Step 2: A 2.5-ml sample of crude extracts in buffer A (15.4 mg of protein) was
mixed with 500 A1 of [35S] methionine-labelled extract (12,000 cpm/4tml), applied to a
1.6cm x 84cm agarose column (Bio-Rad A -0.5m, 200-400 mesh) and the flow rate was
set at 18 ml/h. Fractions (2 ml) were collected, their radioactivity and protein concentration
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Figure 3. Native conformation of RepA. Sedimentation in glycerol gradients (A) or agarose gel filtration (B)
of RepA and of protein standards. Dextran Blue was used to deterrmine the void volume (V,,) and its value was
compared to the protein elution volumes (Ve). RepA was positioned by [35S] radioactivity determination.
measured, and the presence of RepA was analyzed by SDS-PAGE and fluorography.
Step 3: Peak fractions (Fig.2A) were pooled and dyalized against buffer B (20 mM Tris
(pH 8.0), 1 mM EDTA, 5 mM DTT, 5% ethylene glycol) containing 100 mM KCI. The
sample was applied to a 0.9cm x 13cm DEAE Sephacell (Pharmacia) column. The flow
rate was set at 14 ml/h and 4-mi fractions were collected. RepA did not bind to the matrix
in this salt concentration, which resulted in a high degree of purification of the protein
(Fig.2B). Step 4: Peak fractions containing RepA (Fig.2A) were pooled, dialyzed against
buffer B supplemented with 50 mM KCI and applied to a 1.4cm x4cm heparin - agarose
column (Affi-Gel, Bio-Rad). The flow rate was set at 17 ml/h and 0.87-ml fractions were
collected. RepA eluted at 250 mM KCI in a 50 to 500 mM KCI gradient. The protein
seemed to be pure at this stage, as judged by SDS -urea-PAGE and fluorography (Fig.2).
In these gels, the apparent molecular weight of RepA was of 5 kDa, in agreement with
the predicted size deduced from the nucleotide sequence (5112 Da). The final yield of
the purified RepA was 1.6 mg per litre of culture. The protein was concentrated by dialysis
against buffer B (without ethylene glycol), supplemented with 50 mM KCI and 50% glycerol
and stored at -25°C for several months without any appreciable loss of activity, as judged
by its ability to bind to DNA and to protect the ApaLI site from digestion by this enzyme
(31).
Native molecular weight of RepA
The native molecular weight of the protein was determined by sedimentation through a
15% to 35% glycerol gradient and by gel filtration through agarose and comparison to
appropriate molecular weight markers (Fig.3). We could not use gel filtration on Sephadex
because RepA was retained by this matrix, as expected for a basic protein of small size.
From the glycerol gradients (in buffer B, but without ethylene glycol and with 50 mM
KCI), RepA seemed to have a molecular weight of about 9,600 (Fig.3A). From the agarose
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Figure 4. Amino acid sequence determination of RepA. The coding sequence for RepA (coordinates 655 to 792
of pLSl) and the predicted residues from the DNA sequence are shown. The amino acid sequence of the intact
protein was determined by automated protein sequencer analysis. Amino acid identities are indicated by asterisks;
question mark indicates possibility of identity; dash indicates no clear result.
column (in buffer B supplemented with 200 mM KCl), RepA eluted at a position
corresponding to a protein with a molecular weight of 13,400 (Fig.3B). Similar results
were obtained for elutions carried out at 50 or at 500 mM KCl (not shown). An indication
of monomerization of RepA was obtained when the elution was performed at 2 M NaCl
(not shown). We may conclude that, under the experimental conditions employed, RepA
seemed to be synthesized as a dimer of identical subunits.
Amino acid sequence of RepA
Determination of the amino acid sequence of RepA (rather than determination of its amino
terminus) was important to discard any cross contamination with other low-molecular weight
peptides and to determine if the protein was subjected to post-transcriptional processing.
Since RepA would be the first described repressor protein encoded by a Gram-positive
replicon, it was worth unequivocally characterizing the protein. As shown in Figure 4,
the amino acid sequence of RepA coincided with that predicted from the DNA sequence,
although the identification of three residues was uncertain (S29, S33 and G42) and other
four could not be determined (residues E37, K40, E44 and K45). We believe that the
unambiguous characterization of RepA would prove important for future studies on its
secondary and tertiary structures.
Characteristics of RepA
Predictions of the secondary structure and characteristics of RepA were achieved by
computer-assisted programs. The isoelectric point of RepA was predicted to be 9.54, due
to its 9 strongly basic residues. Predictions of the secondary structure of RepA by the
PEPLOT program (29) showed the existence of a clear cahelix-turn-ahelix motif, typical
of many DNA-binding proteins (20). This motif extends from residues 12 to 24 (axhelix-1),
and from residues 29 to 37 (ahelix-2). From residues 5 to 9, a clear jsheet structure is
observable. A relatively high hydrophobic moment was found between residues 12 to 22,
included in the ahelix- 1 of RepA (Fig.5A). This hydrophobic moment predicts that one
part of this region faces the interior of the protein and the other faces the exterior (28).
A flexible segment was also predicted to be between residues 25 to 28 (the turn motif).
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Figure 5. Computer-derived predictions on secondary structure of RepA. A: Drawing of the output of the PEPLOT
program according to ref. 29. The upper part shows the sequence and the sequence schematic of RepA with
the characteristics of the residues indicated on the left and right parts. The Chou and Fasman (38) alpha and
beta conformational potentials, end-predictions and reverse turn potentials are indicated below. The last panels
depict the alpha and beta hydrophobic moments and the hydropathy profile based on the Kyte and Doolitle predictions
(39). B: Drawing of the output of the PLOTCHOUFASMAN computer program. The residues are indicated
and, in the upper part, the predicted regions for ahelix, fsheet or turn motifs are underlined. The amino- and
carboxi-termini of RepA could have a random coil structure. Small boxes indicate the most probable antigenic
sites, which were confirmed by other computer programs.
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Figure 6. (upper) Comparison of the cthelix-tum-ahelix motif of RepA with those of various repressors and
with lambda Cro. Position of first residue and relative residue positions of the DNA-binding domain in the proteins
are indicated. (lower) Comparison of the amino termninus of RepA with homologous regions of various regulatory
proteins. Amino acid positions are indicated in brackets. * indicates amino acid identities; boxed are the functional
homologous residues.
The use of the PLOTCHOUFASMAN program helped to depict the ahelix-tum-ahelix
motif in RepA, although the predicted structures seemed to be slightly displaced as compared
to the PEPLOT predictions (Fig.5B). The most clear antigenic sites were predicted to be
at residues 41 to 43, which was confirmed by a number of different computer programs.
In addition, the ahelix-turn-chelix motif of RepA (Fig.6) fulfils the stereochemical
requirements proposed by Ohlendorf et al. (32). At the relative positions 5 and 9, the
conserved A and G residues are located. Residues at the relative positions 4 (M), 8 (M),
10 (L) and 15 (M) are hydrophobic; at positions 3 (K) and 7 (E) hydrophilic residues
are placed. Accordingly, we could predict that residues at the relative positions 1, 2, 6,
11 -13, 16, 17, and 20 would be involved in the interaction with the DNA when the protein
is bound (32). The general structure of RepA at its DNA-binding motif seems to be in
agreement with that of the well characterized repressor and Cro proteins from phages lambda
and 434. By homology with those proteins, we could define the athelix-I of RepA from
residues 17 to 24 and the cahelix-2 from residues 28 to 36. When we applied the systematic
method of Dodd and Egan (33), the score of RepA for residues at relative positions 1
to 20 (Fig.6) was 1174, close to the 1141 and 1161 values reported for the plasmid RK2
proteins KorB and TrfB, respectively (17). Homologies with a number of repressors (as
well as with Cro proteins from phages lambda and 434) were found at the oahelix-tum-
ahelix motif (Fig.6). Search for homologies between RepA and the P.I.R. data base gave
the highest score for residues 340 to 384 of the human involucrin (33% identity in a 36
amino acids overlap; not shown). The second highest score was obtained with the RK2
repressor TrfB (25% identity in a 32 amino acids overlap). The strongest homology is
located at the amino termini of RepA and TrfB, as was also the case for lambda cHI and
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Figure 7. DNase I protection of the RepA-target DNA by purified RepA protein. Two amounts (0.1I and 1 Azg)
of protein were used; (-) indicates control samples without RepA. Tracks G, CT and AC of sequenced RepA
target DNA are also shown. The nucleotide sequence of the labelled non-ceding strand of pLS 1 and the RepA-
protected sites (boxed) are indicated on the right, as well as the position of the repAB promoter and the ApaLI
restriction site (coordinate 607).
434 Cro (Fig.6). This would suggest a functional role for the amino terminal domain of
these proteins apart from (or in conjunction with) the role of the DNA-binding domain.
Recently, it has been reported (34) that the amino-terminal arm of the lambda repressor
wraps around the DNA and makes contacts in the major groove on the back side of the
DNA. Homologies were also found between the amino terminus of RepA and regions
of the plasmid RI-repressor CopB and of the phage P22 antirepressor (Fig.6). No homology
was found between RepA and the ORF D of the staphylococcal plasmid pNS 1 (35). This
plasmid drew our attention because its ORF D is placed upstream of the postulated
replication initiator protein, showing a genetic arrangement which resembles that of pLS 1.
Characterization of the nature of the cop7 mutation, at the level of its nucleotide sequence,
demonstrated that the mutation consisted in a transversion C to A at coordinate 743. The
result of this single-base change is the substitution of the A30 residue for an E residue.
The copy number of pLS lcop7 was about 160 as compared to the 25 copies of the wild
type plasmid. We have not yet purified the mutant protein, but prediction of its secondary
structure by the above mentioned programs did not show any substantial alteration of it
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Figure 8. Effect of repA product on pLSl copy number analyzed by trans complementation Tests I (A) and
1 (B). Plasmid-bearing pneumococcal cells were transformed with the indicated donor plasmid DNAs and selection
was applied for the incoming plasmid. Crude extracts of various clones were prepared and electrophoresed in
1.2% agarose gels. Homoplasmid strains used as controls are indicated by (-). Chromosomal DNA migrates
at the upper part of the gels and the positions of the covalently closed circular (ccc) monomers of pLS I and
pC194-replicons are indicated. Note a high amount of multimers in the strains harbouring pC194-derived plasmids.
(as compared to the wild type RepA) except for an increase in its average hydrophilicity
and a decrease in its isoelectric point. Nevertheless, since the mutation is placed within
the ahelix-2 of the protein and it resulted in the change of an hydrophobic for a strong
acidic residue, we may assume that the cop7 mutation should affect the affinity of the
RepA7 mutant protein for its target. Based on previous comparisons (36), it appeared that
the repA codon usage was more similar to that of B.subtilis than to E. coli, although the
unfrequently used codon UUG (L, 14% for B.subtilis and 9% for E.coli) was used at
the frequency of 33 %. At present it is still premature to assign this difference to a special
feature of the codon usage of streptococcal genes.
Determination of the target of RepA
The target of RepA within pLS I DNA has been defined to be in the vicinity of the ApaLI
single-site (7). To refine the binding site of RepA, DNase I footprintings were performed
by using two amounts of protein which were bound to the labelled non-coding strand of
pLS1. The results (Fig.7) clearly showed four protected regions located between coordinates
581 to 628. These regions covered the repAB promoter, in which the ApaLI site is located.
No further protected regions were observed and since the three iterons are included in
the labelled fragment, we may conclude that the plasmid three direct repeats (coordinates
534 to 566) are placed outside the target of RepA, confirming previous assumptions (6,31).
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Computer search for the presence of secondary structures or direct repeats in the protected
region showed the possibility of generation of a weak hairpin, centered at coordinate 579
and in which the -35 region of the repAB promoter is included (not shown). Whether
this structure is the actual target of RepA or if a non evident operator structure is present
in this region is a question under current investigation. The binding of RepA at the repAB
promoter, in conjunction with the homologies between RepA and the plasmid-coded
transcriptional repressors TrfB and CopB, suggested to us that the role of RepA would
be at the transcriptional level, by controlling its own synthesis and thus limiting the synthesis
of RepB.
In vivo activity of RepA
Two kinds of complementation tests, based on the quantitative incompatibility tests
developed by Nordstrom et al. (37) were carried out: in Test I, competent pneumococcal
cells carrying either pLS1 or pLS1cop7 were transformed with pCGA3 or pCGA3cop7
DNA (Fig.8A). In Test II, competent S.pneumoniae cells harbouring pCGA3 or
pCGA3cop7 were transformed with either pLS 1 or pLSlcop7 DNA (Fig.8B). In both cases,
selection was done for the donor plasmid (chloramphenicol or tetracycline resistence,
respectively). After plating of the transformants, several colonies of the same size and
incubated for the same period of time were picked, grown and crude extracts were prepared
and analyzed in agarose gels. The number of generations (g) for one single pneumococcal
transformant to give rise to a colony was estimated to be 27 (37). From a colony to a
full grown culture the value of g was estimated to be 10, based on the number of viable
cells per colony, the incubation time, the doubling time of the cultures and the final number
of viable cells. Thus, the g value for all cases was estimated to be 37. The results of these
complementation analyses (Fig.8) can be summarized as follows: when the wild type RepA
was supplied in trans, the number of copies of the wild type plasmid pLS1 was not
significantly affected, but the copy number of the mutant pLS lcop7 was severely reduced.
This effect was not due to a permanent alteration of the pLS1cop7 plasmid because
transformation of the plasmid-free strain with the DNA of these 'low' copy number plasmids
fully restored the cop7 phenotype (not shown). No effect was observed when the mutant
protein RepA7 was given in trans nor when the vector pC 194 was used. The RepA-
conditioned reduction in the copy number of pLS 1 cop7 seemed to be due to a secondary
inhibitor-target interaction rather than to incompatibility caused by a primary inhibitor
(18). This is because no incompatibility towards pLS1 was observable and because no
further reduction in the copy number of pLSlcop7 was detected after 60 generations without
selective pressure. It would thus seem that once the equilibrium in the heteroplasmid
population was reached, no further changes occurred. Furthermore, the results show that
the mutant RepA7 is impaired in its ability to control the plasmid copy number, as expected
from the nature of its mutation. The cop7 mutation leads to a 5-fold increase in the plasmid
copy number without detectable unstabilization, similarly to the copB mutants of plasmid
RI (15). Deletions affecting RepA showed that the protein is not essential for plasmid
maintenance (not shown).
From the results presented here, we may conclude that RepA acts as a modulator of
the copy number of plasmid pLS1 in a secondary control mechanism. It is worth noting
that regulation of plasmid copy number by trans-acting proteins does not seem to be a
common plasmid feature (1). A putative countertranscribed RNA II has been postulated
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to negatively control the pLS1 copy number, most likely being the main replication control
element of the plasmid (4,6).
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